Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, Diseases, drug-drug interaction, Lymphoma (any), Non-Biological, Therapies, Combinations, Non-Hodgkin Lymphoma, T-Cell Lymphoma, immunotherapy, Study Population, Lymphoid Malignancies, infusion, Clinically relevant, transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, Diseases, drug-drug interaction, Lymphoma (any), Non-Biological, Therapies, Combinations, Non-Hodgkin Lymphoma, T-Cell Lymphoma, immunotherapy, Study Population, Lymphoid Malignancies, infusion, Clinically relevant, transplantation
Saturday, December 5, 2020: 7:30 AM-9:00 AM
Moderators:
Stefan K. Barta, MD, MRCP, MS, Lymphoma Program, Abramson Cancer Center, University of Pennsylvania
and
Deepa Jagadeesh, MD, MPH, Cleveland Clinic
Disclosures:
Barta: Monsanto: Consultancy; Atara: Honoraria; Seattle Genetics: Honoraria, Research Funding; Janssen: Honoraria; Pfizer: Honoraria; Acrotech: Honoraria. Jagadeesh: Regeneron: Research Funding; Seattle Genetics: Membership on an entity's Board of Directors or advisory committees, Research Funding; Verastem: Membership on an entity's Board of Directors or advisory committees; MEI Pharma: Research Funding; Debiopharm Group: Research Funding.
7:30 AM
7:45 AM
8:00 AM
8:15 AM
8:30 AM
8:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH